{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:49:20Z","timestamp":1787633360725,"version":"build-2736575974"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Given that the sterility of urine and the urinary tract has been questioned by research, urinary microbiome dysbiosis has been recognized as one of the potential cancer-promoting factors. The composition of the urinary microbial community in healthy individuals has a relatively high similarity at the phylum level, with factors like age and gender influencing the expression and distribution. In contrast, the urinary microbiome of patients with urologic cancers shows significant variability and diversity depending on the type of cancer. Most of the early studies focused on the distribution, aggregation, and expression of microbiota in urologic cancers, warranting advanced studies on the causal relationship between microbes and urologic cancers. Bladder and prostate cancer tumorigenesis and progression can be influenced by microbes through chronic inflammatory or immunomodulatory pathways making them cancer models strongly associated with the urinary microbiome. Here, we summarize the expression characteristics of the microbiomes associated with these cancers and analyze the pathophysiological mechanisms and signaling pathways of the microbiome in the tumor promotion or suppression. By examining the role played by the urinary microbiome in the pathogenesis of urologic cancers, we assess the potential of specific microbial groups as biomarkers for diagnosis and surveillance. Additionally, involving the microbiome or using adjunctive participation in tumor therapy is becoming an emerging cancer treatment option. Improving urinary microbial homeostasis in urinary cancers by direct treatment with microbial products, microbial co-immunotherapy, probiotic-assisted therapy, and fecal microbial transplantation may broaden the scope of therapy and enhance the efficacy of conventional medicines.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1699308","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T22:31:16Z","timestamp":1763073076000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Deciphering the urinary microbiome and urological cancers: from correlation to mechanisms and treatment"],"prefix":"10.3389","volume":"16","author":[{"given":"Zunwen","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guandu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/atm.2016.12.69","article-title":"The mycobiome of the human urinary tract: potential roles for fungi in urology","volume":"5","author":"Ackerman","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.euf.2016.11.001","article-title":"The urinary tract microbiome in health and disease","volume":"4","author":"Arag\u00f3n","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.euf.2018.08.001","article-title":"Male bladder microbiome relates to lower urinary tract symptoms","volume":"6","author":"Bajic","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"101191","DOI":"10.1016\/j.mtbio.2024.101191","article-title":"Applications of pyroptosis activators in tumor immunotherapy","volume":"28","author":"Bao","year":"2024","journal-title":"Mater Today Bio"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1099\/jmm.0.001058","article-title":"Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer","volume":"68","author":"Bi","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"12157","DOI":"10.1038\/s41598-018-29054-w","article-title":"The urinary microbiome associated with bladder cancer","volume":"8","author":"Bu\u010devi\u0107 Popovi\u0107","year":"2018","journal-title":"Sci. Rep."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.euros.2022.06.005","article-title":"Human gut mycobiome and fungal community interaction: the unknown musketeer in the chemotherapy response status in bladder Cancer","volume":"43","author":"Bukavina","year":"2022","journal-title":"Eur. Urol. Open Sci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/pros.24763","article-title":"A prospective evaluation of the prostate microbiome in malignant and benign tissue using transperineal biopsy","volume":"84","author":"Chen","year":"2024","journal-title":"Prostate"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/life13071486","article-title":"An overview of the microbiota of the human urinary tract in health and disease: current issues and perspectives","volume":"13","author":"Colella","year":"2023","journal-title":"Life"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molmet.2018.05.016","article-title":"Sexual dimorphism of cardiometabolic dysfunction: gut microbiome in the play?","volume":"15","author":"Cross","year":"2018","journal-title":"Mol. Metab."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13027-016-0074-9","article-title":"Frequency and typing of propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer","volume":"11","author":"Davidsson","year":"2016","journal-title":"Infect. Agent Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","article-title":"Prostate carcinogenesis: inflammatory storms","volume":"20","author":"de Bono","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.eururo.2016.10.008","article-title":"Global burden of urologic cancers, 1990-2013","volume":"71","author":"Dy","year":"2017","journal-title":"Eur. Urol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-9378-7-19","article-title":"Role of chronic E. coli infection in the process of bladder cancer- an experimental study","volume":"7","author":"El-Mosalamy","year":"2012","journal-title":"Infect. Agents Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1479-5876-10-174","article-title":"Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury","volume":"10","author":"Fouts","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/cancers15051375","article-title":"The gut-prostate axis: a new perspective of prostate cancer biology through the gut microbiome","volume":"15","author":"Fujita","year":"2023","journal-title":"Cancers (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5534\/wjmh.180040","article-title":"Role of androgen receptor in prostate cancer: a review","volume":"37","author":"Fujita","year":"2019","journal-title":"World J. Mens Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.21037\/atm.2019.06.56","article-title":"Human microbial ecology and the rising new medicine","volume":"7","author":"Godoy-Vitorino","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","article-title":"The role of gut microbiome in the pathogenesis of prostate cancer: a prospective, pilot study","volume":"111","author":"Golombos","year":"2018","journal-title":"Urology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/life13030812","article-title":"The urinary microbiome and bladder cancer","volume":"13","author":"Heidar","year":"2023","journal-title":"Life"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12894-020-0576-z","article-title":"Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy","volume":"20","author":"Hourigan","year":"2020","journal-title":"BMC Urol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12885-024-12018-x","article-title":"Gut microbiota in patients with prostate cancer: a systematic review and meta-analysis","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"370.e9","DOI":"10.1016\/j.urolonc.2020.12.011","article-title":"Investigating the association between the urinary microbiome and bladder cancer: an exploratory study","volume":"39","author":"Hussein","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fcimb.2016.00014","article-title":"The basics of bacteriuria: strategies of microbes for persistence in urine","volume":"6","author":"Ipe","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/pros.24063","article-title":"Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells","volume":"80","author":"Jain","year":"2020","journal-title":"Prostate"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"106992","DOI":"10.1016\/j.phrs.2023.106992","article-title":"Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: a longitudinal hybrid radiological model","volume":"198","author":"Jin","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/jid.2014.290","article-title":"Propionibacterium acnes promotes Th17 and Th17\/Th1 responses in acne patients","volume":"135","author":"Kistowska","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/apm.13011","article-title":"Bacillus Calmette-Gu\u00e9rin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections","volume":"128","author":"Larsen","year":"2020","journal-title":"APMIS"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fcimb.2013.00041","article-title":"The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults","volume":"3","author":"Lewis","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","article-title":"Short-chain fatty acids and cancer","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2328868","DOI":"10.1080\/19490976.2024.2328868","article-title":"Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"911325","DOI":"10.3389\/fimmu.2022.911325","article-title":"Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/mdr2.70022","article-title":"The dual role of exosomes in the tumor microenvironment: from pro-tumorigenic signaling to immune modulation","volume":"1","author":"Li","year":"2025","journal-title":"Med. Res."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.semcancer.2022.05.014","article-title":"Nanomedicine for urologic cancers: diagnosis and management","volume":"86","author":"Li","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","article-title":"Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer","volume":"74","author":"Liss","year":"2018","journal-title":"Eur. Urol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1002\/cam4.2419","article-title":"Dysbiosis signatures of the microbial profile in tissue from bladder cancer","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.trecan.2024.02.009","article-title":"Into the era of mycobiome-driven cancer research","volume":"10","author":"Liu","year":"","journal-title":"Trends Cancer"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"104322","DOI":"10.1016\/j.critrevonc.2024.104322","article-title":"Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies","volume":"196","author":"Liu","year":"","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.cancergen.2024.08.057","article-title":"Advancing bladder carcinoma diagnosis: the innovative potential of the BCDx multi-omics approach","author":"Liyanage","year":"2024","journal-title":"Cancer Genet."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4824909","DOI":"10.1155\/2019\/4824909","article-title":"Common core bacterial biomarkers of bladder cancer based on multiple datasets","volume":"2019","author":"Mai","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"759","DOI":"10.5534\/wjmh.220202","article-title":"Emerging relationship between the gut microbiome and prostate cancer","volume":"41","author":"Matsushita","year":"2023","journal-title":"World J. Mens Health"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ijc.34028","article-title":"High-fat diet promotes prostate cancer growth through histamine signaling","volume":"151","author":"Matsushita","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1158\/0008-5472.CAN-20-4090","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling","volume":"81","author":"Matsushita","year":"","journal-title":"Cancer Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1111\/cas.14998","article-title":"The gut microbiota associated with high-Gleason prostate cancer","volume":"112","author":"Matsushita","year":"","journal-title":"Cancer Sci."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2016.09.003","article-title":"Urinary tract infection: pathogenesis and outlook","volume":"22","author":"McLellan","year":"2016","journal-title":"Trends Mol. Med."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.euros.2022.11.023","article-title":"Defining the mycobiome in bladder cancer","volume":"48","author":"Mercier","year":"2023","journal-title":"Eur. Urol. Open Sci."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"111619","DOI":"10.1016\/j.biopha.2021.111619","article-title":"Role of microbiota-derived short-chain fatty acids in cancer development and prevention","volume":"139","author":"Mirzaei","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world health organization classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur. Urol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature14139","article-title":"Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation","volume":"521","author":"Moon","year":"2015","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1128\/CMR.12.1.97","article-title":"Relationship between schistosomiasis and bladder cancer","volume":"12","author":"Mostafa","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1442-2042.2012.03101.x","article-title":"Inflammation and prostate carcinogenesis","volume":"20","author":"Nakai","year":"2013","journal-title":"Int. J. Urol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.euros.2023.11.003","article-title":"Microbiome profiling in bladder cancer patients using the first-morning urine sample","volume":"59","author":"Nardelli","year":"2024","journal-title":"Eur. Urol. Open Sci."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cancergen.2025.03.004","article-title":"Identification of new immune target and signaling for cancer immunotherapy","author":"Narote","year":"2025","journal-title":"Cancer Genet."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e36298","DOI":"10.1371\/journal.pone.0036298","article-title":"Bacterial communities of the coronal sulcus and distal urethra of adolescent males","volume":"7","author":"Nelson","year":"2012","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 world health organization classification of tumors of the urinary system and male genital organs-part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur. Urol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e00218-20","DOI":"10.1128\/mBio.00218-20","article-title":"Advances in understanding the human urinary microbiome and its potential role in urinary tract infection","volume":"11","author":"Neugent","year":"2020","journal-title":"MBio"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/82_2011_187","article-title":"Lactobacillus: host-microbe relationships","volume":"358","author":"O\u2019Callaghan","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/JU.0000000000001336","article-title":"The microbiome of catheter collected urine in males with bladder Cancer according to disease stage","volume":"205","author":"Oresta","year":"2021","journal-title":"J. Urol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"718776","DOI":"10.3389\/fmicb.2021.718776","article-title":"Profiling the bladder microbiota in patients with bladder cancer","volume":"12","author":"Parra-Grande","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e01283","DOI":"10.1128\/mBio.01283-14","article-title":"The female urinary microbiome: a comparison of women with and without urgency urinary incontinence","volume":"5","author":"Pearce","year":"2014","journal-title":"MBio"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.eururo.2021.05.018","article-title":"Is there a detrimental effect of antibiotic therapy in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab?","volume":"80","author":"Pederzoli","year":"2021","journal-title":"Eur. Urol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.euo.2020.04.002","article-title":"Sex-specific alterations in the urinary and tissue microbiome in therapy-na\u00efve urothelial bladder Cancer patients","volume":"3","author":"Pederzoli","year":"2020","journal-title":"Eur. Urol. Oncol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.eururo.2023.12.014","article-title":"Stool microbiome signature associated with response to neoadjuvant pembrolizumab in patients with muscle-invasive bladder cancer","volume":"85","author":"Pederzoli","year":"2024","journal-title":"Eur. Urol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41585-023-00795-2","article-title":"The potential role of the microbiota in prostate cancer pathogenesis and treatment","volume":"20","author":"Pernigoni","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.abf8403","article-title":"Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis","volume":"374","author":"Pernigoni","year":"2021","journal-title":"Science"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"8849","DOI":"10.3390\/ijms23168849","article-title":"Prostate infiltration by treg and Th17 cells as an immune response to propionibacterium acnes infection in the course of benign prostatic hyperplasia and prostate cancer","volume":"23","author":"Radej","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/cam4.3694","article-title":"Modulatory effects of gut microbiome in cancer immunotherapy: a novel paradigm for blockade of immune checkpoint inhibitors","volume":"10","author":"Rezasoltani","year":"2021","journal-title":"Cancer Med."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cmi.2022.08.010","article-title":"The urobiome in men and women: a clinical review","volume":"29","author":"Roth","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.clgc.2023.12.015","article-title":"Bladder cancer and the urinary microbiome-new insights and future directions: a review","volume":"22","author":"Russo","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/gutjnl-2022-327952","article-title":"Fungi and cancer","volume":"72","author":"Saftien","year":"2023","journal-title":"Gut"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","article-title":"The inflammatory microenvironment and microbiome in prostate cancer development","volume":"15","author":"Sfanos","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mdr2.70023","article-title":"Identifying potential vulnerability to long COVID through global-to-local inequalities in years lived with disability attributed to COVID-19, 2020\u20132021, across 920 locations","volume":"1","author":"Shan","year":"2025","journal-title":"Med. Res."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00192-019-03931-y","article-title":"Bladder urinary oxygen tension is correlated with urinary microbiota composition","volume":"30","author":"Shannon","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/pros.22648","article-title":"A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of propionibacterium acnes","volume":"73","author":"Shinohara","year":"2013","journal-title":"Prostate"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4111\/icu.20210312","article-title":"Urobiome: an outlook on the metagenome of urological diseases","volume":"62","author":"Shoemaker","year":"2021","journal-title":"Investig. Clin. Urol."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2180-11-244","article-title":"Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons","volume":"11","author":"Siddiqui","year":"2011","journal-title":"BMC Microbiol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: past, present, and future","author":"Sonkin","year":"2024","journal-title":"Cancer Genet."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00345-024-05173-0","article-title":"A review of urinary bladder microbiome in patients with bladder cancer and its implications in bladder pathogenesis","volume":"42","author":"Stamatakos","year":"2024","journal-title":"World. J. Urol."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41585-022-00668-0","article-title":"The composition and influence of the gut mycobiome in bladder cancer","volume":"19","author":"Stone","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41396-023-01483-0","article-title":"Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy","volume":"17","author":"Sun","year":"2023","journal-title":"ISME J."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41522-025-00678-x","article-title":"Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation","volume":"11","author":"Sun","year":"2025","journal-title":"NPJ Biofilms Microb."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/s41467-018-03968-5","article-title":"Culturing of female bladder bacteria reveals an interconnected urogenital microbiota","volume":"9","author":"Thomas-White","year":"2018","journal-title":"Nat. Commun."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/cells11050803","article-title":"Antibody-drug conjugates in urothelial carcinoma: a new therapeutic opportunity moves from bench to bedside","volume":"11","author":"Ungaro","year":"2022","journal-title":"Cells"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.toxlet.2009.12.018","article-title":"Environmental factors and genetic susceptibility promote urinary bladder cancer","volume":"193","author":"Volanis","year":"2010","journal-title":"Toxicol. Lett."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrurol.2013.322","article-title":"Reducing infection rates after prostate biopsy","volume":"11","author":"Wagenlehner","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12967-024-05446-7","article-title":"Urinary microbiome dysbiosis is associated with an inflammatory environment and perturbed fatty acids metabolism in the pathogenesis of bladder cancer","volume":"22","author":"Wu","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fcimb.2018.00167","article-title":"Profiling the urinary microbiota in male patients with bladder Cancer in China","volume":"8","author":"Wu","year":"","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fcimb.2018.00429","article-title":"Corrigendum: profiling the urinary microbiota in male patients with bladder Cancer in China","volume":"8","author":"Wu","year":"","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcancer.2025.01.002","article-title":"Fungi, immunosenescence and cancer","volume":"109","author":"Xu","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref97","first-page":"57","article-title":"Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma","volume":"2","author":"Xu","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.semcancer.2021.12.010","article-title":"Urinary microbiota and bladder cancer: a systematic review and a focus on uropathogens","volume":"86","author":"Yacouba","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"187","DOI":"10.15698\/mic2024.05.824","article-title":"From microbes to medicine: harnessing the gut microbiota to combat prostate cancer","volume":"11","author":"Yadav","year":"2024","journal-title":"Microb. Cell"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal microbiota transplantation: current challenges and future landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"101487","DOI":"10.1016\/j.xcrm.2024.101487","article-title":"Microbiome bacterial influencers of host immunity and response to immunotherapy","volume":"5","author":"Yousefi","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"106633","DOI":"10.1016\/j.phrs.2022.106633","article-title":"Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer","volume":"188","author":"Zhang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"107185","DOI":"10.1016\/j.phrs.2024.107185","article-title":"Unveiling intratumoral microbiota: an emerging force for colorectal cancer diagnosis and therapy","volume":"203","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3390\/cancers15030809","article-title":"Urinary eubacterium sp. CAG:581 promotes non-muscle invasive bladder cancer (NMIBC) development through the ECM1\/MMP9 pathway","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancer"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-\u03baB-IL6-STAT3 axis","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"e105320","DOI":"10.15252\/embj.2020105320","article-title":"Fungal-induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL-22","volume":"40","author":"Zhu","year":"2021","journal-title":"EMBO J."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1699308\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T22:31:17Z","timestamp":1763073077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1699308\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":106,"alternative-id":["10.3389\/fmicb.2025.1699308"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1699308","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"article-number":"1699308"}}